Review

Risk Adaptive Neoadjuvant Chemotherapy in Muscle Invasive Bladder Cancer
  • Elif Atağ
  • Aziz Karaoğlu
  • Ömer Küçük
Bull Urooncol 2017; 16: 57-62 DOI: 10.4274/uob.763
Neoadjuvant and adjuvant chemotherapy for muscle invasive bladder cancer
  • Aziz Karaoğlu
  • Utku Oflazoğlu
  • Necla Demir
Bull Urooncol 2013; 12: 58-63
Neoadjuvant and adjuvant treatment modalities for prostate cancer
  • Erkan Erkan
  • Gökhan Toktaş
Bull Urooncol 2011; 10: 63-69
Adjuvant and Neoadjuvant Targeted Therapies in Locally Advanced Renal Cell Carcinoma
  • Ozan Bozkurt
  • Ömer Demir
Bull Urooncol 2014; 13: 139-145 DOI: 10.4274/uob.82
Neoadjuvant targeted therapy in renal cell carcinoma
  • Sertaç Yazıcı
  • Halil Kızılöz
  • Haluk Özen
Bull Urooncol 2012; 11: 240-245

Medical Oncology

Neoadjuvant chemotherapy in muscle invasive bladder cancer
  • Evren Süer
  • Kadir Türkölmez
Bull Urooncol 2012; 11: 74-78

Case Report

Impact of Neoadjuvant Sunitinib Treatment on Tumour Thrombi in the Inferior Vena Cava in Metastatic Renal Cell Carcinoma
  • Akos Berczi
  • Tibor Flasko
  • Tamas Szerafin
  • Balazs Juhasz
  • Csaba Berczi
Bull Urooncol 2020; 19: 162-164 DOI: 10.4274/uob.galenos.2020.1548

Original Article

Effect of Neoadjuvant Hormonal Treatment on the Necessity of Secondary Radiotherapy in Patients Undergoing Radical Prostatectomy for High-Risk Prostate Cancer
  • Csaba Berczi
  • Janos Docs
  • Ben Thomas
  • Zsolt Bacso
  • Tibor Flasko
Bull Urooncol 2021; 20: 219-224 DOI: 10.4274/uob.galenos.2021.2021.9.1
Urologists’ Role and Attitude in the Systemic Treatment of Urologic Cancers
  • Serdar Madendere
  • Müslim Doğan Değer
  • Engin Denizhan Demirkıran
  • Hüseyin Alperen Yıldız
Bull Urooncol 2021; 20: 264-269 DOI: 10.4274/uob.galenos.2021.2021.8.2